Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AMEH

AMEH - Apollo Medical Holdings Inc Stock Price, Fair Value and News

38.75USD-0.51 (-1.30%)Market Closed
Watchlist

Market Summary

USD38.75-0.51
Market Closed
-1.30%

AMEH Stock Price

View Fullscreen

AMEH RSI Chart

AMEH Valuation

Market Cap

2.3B

Price/Earnings (Trailing)

50.6

Price/Sales (Trailing)

1.7

EV/EBITDA

16.91

Price/Free Cashflow

20.25

AMEH Price/Sales (Trailing)

AMEH Profitability

EBT Margin

7.48%

Return on Equity

7.52%

Return on Assets

4.16%

Free Cashflow Yield

4.94%

AMEH Fundamentals

AMEH Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

9.83%

Rev. Growth (Qtr)

-0.01%

AMEH Earnings

Earnings (TTM)

44.6M

Earnings Growth (Yr)

-4.86%

Earnings Growth (Qtr)

67.49%

Breaking Down AMEH Revenue

Last 7 days

3.3%

Last 30 days

5.0%

Last 90 days

9.6%

Trailing 12 Months

11.4%

How does AMEH drawdown profile look like?

AMEH Financial Health

Current Ratio

2.35

Debt/Equity

0.35

Debt/Cashflow

0.65

AMEH Investor Care

Shares Dilution (1Y)

2.75%

Diluted EPS (TTM)

0.95

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.2B1.3B1.3B0
2022861.1M955.2M1.0B1.1B
2021698.1M708.6M755.6M773.9M
2020630.0M695.2M705.7M717.4M
2019491.7M499.1M488.5M560.6M
2018394.9M476.0M545.6M519.9M
2017128.0M157.2M239.7M356.4M
201644.0M46.2M49.5M54.5M
201533.0M39.1M38.8M41.8M
201410.8M12.1M20.9M25.7M
20136.6M7.1M9.3M10.3M
20125.1M5.7M6.3M6.8M
20113.9M4.2M4.5M4.8M
20100000

Tracking the Latest Insider Buys and Sells of Apollo Medical Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 23, 2024
kumar dinesh m.
acquired
-
-
150,395
see remarks
Dec 15, 2023
marsh linda
acquired
-
-
3,650
-
Dec 15, 2023
mazdyasni matthew
acquired
-
-
4,750
-
Dec 15, 2023
vong john
acquired
-
-
14,352
chief accounting officer
Dec 15, 2023
dai, weili
acquired
-
-
3,650
-
Dec 15, 2023
chiang john
acquired
-
-
4,750
-
Dec 15, 2023
schmidt david
acquired
-
-
5,750
-
Dec 15, 2023
lam thomas s.
acquired
-
-
90,000
president and co-ceo
Dec 15, 2023
sim kenneth t.
acquired
-
-
90,000
executive chairman
Dec 15, 2023
kitayama mitchell w
acquired
-
-
6,750
-

1–10 of 50

Which funds bought or sold AMEH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 20, 2024
Quarry LP
new
-
8,503
8,503
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
3.78
255,000
1,141,000
-%
Feb 15, 2024
Legal & General Group Plc
reduced
-1.4
836,189
4,567,780
-%
Feb 15, 2024
JANE STREET GROUP, LLC
new
-
2,008,450
2,008,450
-%
Feb 15, 2024
State of Wyoming
added
387
147,180
176,333
0.03%
Feb 15, 2024
BARCLAYS PLC
added
197
1,883,000
2,582,000
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
38.00
38.00
-%
Feb 14, 2024
BNP PARIBAS FINANCIAL MARKETS
reduced
-27.15
-85,261
806,828
-%
Feb 14, 2024
Balyasny Asset Management L.P.
sold off
-100
-403,950
-
-%
Feb 14, 2024
Ameritas Investment Partners, Inc.
unchanged
-
31,715
163,043
0.01%

1–10 of 43

Are Funds Buying or Selling AMEH?

Are funds buying AMEH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AMEH
No. of Funds

Unveiling Apollo Medical Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.66%
5,049,928
SC 13G/A
Jan 23, 2024
blackrock inc.
13.5%
6,498,075
SC 13G/A
Nov 17, 2023
allied physicians of california, a profession medical corp
12.9%
7,132,698
SC 13D/A
Feb 09, 2023
vanguard group inc
7.83%
4,438,955
SC 13G/A
Jan 26, 2023
blackrock inc.
11.5%
6,514,440
SC 13G/A
Jan 20, 2023
blackrock inc.
11.5%
6,514,440
SC 13G/A
Feb 09, 2022
vanguard group inc
7.02%
3,897,315
SC 13G
Jan 28, 2022
blackrock inc.
10.7%
5,960,508
SC 13G/A
Oct 08, 2021
blackrock inc.
10.6%
5,867,352
SC 13G
Jul 08, 2021
allied physicians of california, a profession medical corp
20.0%
10,993,301
SC 13D/A

Recent SEC filings of Apollo Medical Holdings Inc

View All Filings
Date Filed Form Type Document
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 02, 2024
8-K
Current Report
Jan 26, 2024
8-K
Current Report
Jan 24, 2024
3
Insider Trading
Jan 24, 2024
4
Insider Trading
Jan 24, 2024
8-K
Current Report
Jan 23, 2024
SC 13G/A
Major Ownership Report
Jan 10, 2024
8-K
Current Report
Jan 02, 2024
8-K
Current Report
Dec 19, 2023
4
Insider Trading

What is the Fair Value of AMEH?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Apollo Medical Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
482.7B
360.0B
0.01% 5.90%
22.26
1.34
14.24% 11.62%
97.2B
357.8B
0.71% -14.01%
11.63
0.27
10.95% 93.52%
82.4B
65.0B
9.34% 20.24%
15.73
1.27
7.86% -7.11%
42.1B
154.0B
-0.09% 8.25%
15.58
0.27
6.54% 124.79%
11.2B
14.0B
2.25% 10.28%
16.63
0.8
6.03% -8.61%
10.6B
12.1B
12.03% 47.11%
15.32
0.87
4.57% 23.40%
MID-CAP
8.9B
2.2B
0.13% 16.69%
36.28
3.99
4.50% -6.69%
7.7B
2.9B
-3.46% 1.96%
-422.68
2.7
13.16% -106.47%
2.2B
4.1B
-19.95% -33.62%
7.97
0.55
-25.26% -41.31%
SMALL-CAP
2.3B
1.3B
4.99% 11.37%
50.6
1.7
27.06% -27.04%
1.5B
1.0B
8.40% -11.51%
25.7
1.44
10.84% 30.19%
1.2B
3.0B
7.30% 124.36%
-6.15
0.39
6.74% 20.73%
41.9M
-
-0.60% -54.62%
-2.89
-
- -27.68%
16.9M
20.7M
- -15.62%
83.17
0.82
6.53% -85.60%

Apollo Medical Holdings Inc News

Latest updates
MarketBeat4 hours ago
Yahoo Finance Australia19 Feb 202404:40 pm
Simply Wall St07 Feb 202408:00 am

Apollo Medical Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue0.0%34834833729431727026319522717617617718016519516517915613096.00107
Costs and Expenses-3.8%30932131528226725423719317415515413714315218916116814611599.00-
Operating Expenses-----------------16814611599.00105
  S&GA Expenses22.3%29.0024.0021.0024.0021.0020.0012.0017.0022.0014.009.009.0016.0012.00-12.0011.008.0012.0010.0012.00
EBITDA Margin-4.1%0.10*0.10*0.09*0.10*0.07*0.03*0.11*0.13*0.20*0.27*0.32*0.29*---------
Interest Expenses4.0%4.004.003.003.002.002.001.001.001.002.002.001.002.003.00-3.003.001.000.000.000.00
Income Taxes-28.3%10.0014.007.0011.0017.005.007.00-4.28-0.2828.008.0013.0011.0032.00-2.002.004.004.00-1.41-0.98
Earnings Before Taxes20.7%38.0031.0019.0010.0041.0017.0018.00-22.43-5.5084.0021.0024.0036.001136.005.000.0014.0015.00-3.86-2.92
EBT Margin-5.4%0.07*0.08*0.07*0.08*0.05*0.01*0.09*0.10*0.16*0.23*0.28*0.25*---------
Net Income67.5%22.0013.0013.00-3.7323.0012.0014.0012.0034.0010.0012.0010.0017.007.006.004.007.004.004.000.00-3.10
Net Income Margin-4.8%0.03*0.04*0.04*0.04*0.06*0.08*0.08*0.09*0.09*0.07*0.07*0.06*---------
Free Cashflow-21.9%11.0014.002.0084.00-39.088.007.00-14.9942.0014.0010.00-3.21---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets4.5%1,0731,027999966955967923867871896843817814833724729750568521513552
  Current Assets2.4%476465455428446468445404427472370339367381318329321168177173203
    Cash Equivalents-6.8%27429427528818423423823320517720619316615281.0010423053.0093.00108120
  Net PPE-----------------12.0012.0012.0013.0013.00
  Goodwill0.5%276274269269251247246246237232232232239239239239237209186186190
Liabilities3.2%458444434408410447397357346356382372386414369368382163126106142
  Current Liabilities9.2%20318617314915618515611511512612311513115310710510578.0088.0072.0092.00
  Long Term Debt0.5%206205205203199199183183183183227230226230230232234----
    LT Debt, Current13.7%3.003.001.001.003.002.002.001.000.000.0012.0011.0010.0010.0010.0010.0010.00----
    LT Debt, Non Current0.5%206205205203199199183183183183227230226230230232234----
Shareholder's Equity4.2%594570551543504480473454435399347329229208198192192186182182185
  Retained Earnings10.6%23120919618218616315113712590.0080.0070.0060.0043.0036.0032.0025.0021.0018.0018.0017.00
  Additional Paid-In Capital1.6%363357353360315311316311306306266261169164161160166164163163163
Shares Outstanding0.1%47.0047.0046.0047.0045.0045.0045.0045.0044.0044.0043.0042.00---------
Minority Interest6.8%4.004.003.002.003.006.006.006.004.003.001.000.001.001.001.001.001.001.001.001.005.00
Float------1,500---2,400---504---480---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-40.3%15,40525,8027,72084,939-35,8709,02124,038-12,19051,23921,3349,952-2,60136,18921,868-9,2933,58832,102-18,050-3,967-6,36818,449
  Share Based Compensation35.4%5,7064,2133,4455,6243,5023,9203,0552,4231,4201,5561,3468256009001,058541330331345202202
Cashflow From Investing-572.5%-34,875-5,186-14,03513,201-8,0867,497-19,72539,084-12,742-10,49469229,096-75368,093-943-120,267-10,117-50,135-112-4,93417.00
Cashflow From Financing47.0%-510-963-7,0995,871-6,251-20,2375321,435-11,016-39,4291,262647-21,795-18,487-12,061-10,376152,07631,441-9,810-5,802-3,642
  Dividend Payments97.2%1,4247221201,35412011,3781,178-9,97921,1064.001,18619,946-9,9341,04749,72894210,0004,2164,726
  Buy Backs-98.4%1509,539--4231689,300230-2,7582,639342-1,0227713624267,530--40.005,047-

AMEH Income Statement

2023-09-30
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue    
Total revenue$ 348,173$ 317,001$ 1,033,625$ 849,955
Operating expenses    
Cost of services, excluding depreciation and amortization275,375240,768857,648691,566
General and administrative expenses29,41021,38874,64853,224
Depreciation and amortization4,3054,75412,84613,480
Total expenses309,090266,910945,142758,270
Income from operations39,08350,09188,48391,685
Other income (expense)    
(Loss) income from equity method investments(2,104)1,4523,1044,397
Interest expense(3,779)(2,422)(10,680)(5,348)
Interest income3,2812239,617690
Unrealized loss on investments(342)(6,763)(5,875)(17,591)
Other income (expense)1,876(1,318)4,2652,328
Total other (expense) income, net(1,068)(8,828)431(15,524)
Income before provision for income taxes38,01541,26388,91476,161
Provision for income taxes10,04217,36630,97129,537
Net income27,97323,89757,94346,624
Net income (loss) attributable to non-controlling interest5,9147129,582(2,275)
Net income attributable to Apollo Medical Holdings, Inc.$ 22,059$ 23,185$ 48,361$ 48,899
Earnings per share – basic (in dollars per share)$ 0.47$ 0.52$ 1.04$ 1.09
Earnings per share – diluted (in dollars per share)$ 0.47$ 0.50$ 1.03$ 1.06
Weighted average shares of common stock outstanding – basic (in shares)46,547,50244,946,72546,527,35044,795,295
Weighted average shares of common stock outstanding – diluted (in shares)46,920,60746,152,53646,881,56745,993,001
Capitation, net    
Revenue    
Total revenue$ 305,678$ 227,571$ 906,430$ 677,253
Risk pool settlements and incentives    
Revenue    
Total revenue15,02264,84948,605101,717
Management fee income    
Revenue    
Total revenue9,89810,03032,28730,487
Fee-for-service, net    
Revenue    
Total revenue15,89212,85941,21635,694
Other revenue    
Revenue    
Total revenue$ 1,683$ 1,692$ 5,087$ 4,804

AMEH Balance Sheet

2023-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 273,941$ 288,027
Investments in marketable securities3,0215,567
Other receivables1,5011,834
Prepaid expenses and other current assets13,95314,798
Total current assets476,229428,125
Non-current assets  
Land, property, and equipment, net128,575108,536
Intangible assets, net74,20976,861
Goodwill275,528269,053
Income taxes receivable15,94315,943
Loan receivable, non-current25,0400
Investments in other entities – equity method44,42840,299
Investments in privately held entities2,896896
Restricted cash3450
Operating lease right-of-use assets21,48220,444
Other assets8,5866,056
Total non-current assets597,032538,088
Total assets[1]1,073,261966,213
Current liabilities  
Accounts payable and accrued expenses53,13649,562
Fiduciary accounts payable6,2578,065
Medical liabilities97,51981,255
Income taxes payable30,1124,279
Dividend payable638664
Finance lease liabilities655594
Operating lease liabilities3,5283,572
Current portion of long-term debt2,991619
Other liabilities8,1210
Total current liabilities202,957148,610
Non-current liabilities  
Deferred tax liability12,14514,217
Finance lease liabilities, net of current portion1,1951,275
Operating lease liabilities, net of current portion21,00619,915
Long-term debt, net of current portion and deferred financing costs206,213203,389
Other long-term liabilities14,10520,260
Total non-current liabilities254,664259,056
Total liabilities[1]457,621407,666
Commitments and contingencies (Note 12)
Mezzanine equity  
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation17,93114,237
Stockholders’ equity  
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,607,356 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of September 30, 2023 and December 31, 2022, respectively4747
Additional paid-in capital362,889360,097
Retained earnings230,778182,417
Total stockholders’ equity593,714542,561
Non-controlling interest3,9951,749
Total equity597,709544,310
Total liabilities, mezzanine equity and equity1,073,261966,213
Series A Preferred Stock  
Stockholders’ equity  
Preferred stock00
Series B Preferred Stock  
Stockholders’ equity  
Preferred stock00
Nonrelated Party  
Current assets  
Receivables, net95,89249,631
Loans receivable973996
Related Party  
Current assets  
Receivables, net86,94865,147
Loans receivable$ 0$ 2,125
[1]The Company’s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $554.0 million and $523.7 million as of September 30, 2023 and December 31, 2022, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $142.4 million and $131.8 million as of September 30, 2023 and December 31, 2022, respectively. The VIE balances do not include $317.7 million of investment in affiliates and $16.3 million of amounts due to affiliates as of September 30, 2023 and $304.8 million of investment in affiliates and $30.3 million of amounts due from affiliates as of December 31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 — “Variable Interest Entities (VIEs)” for further detail.
AMEH
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.
 CEO
 WEBSITEwww.apollomed.net
 EMPLOYEES1362

Apollo Medical Holdings Inc Frequently Asked Questions


What is the ticker symbol for Apollo Medical Holdings Inc? What does AMEH stand for in stocks?

AMEH is the stock ticker symbol of Apollo Medical Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Apollo Medical Holdings Inc (AMEH)?

As of Wed Feb 21 2024, market cap of Apollo Medical Holdings Inc is 2.26 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers. The fair value of Apollo Medical Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Apollo Medical Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMEH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Apollo Medical Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether AMEH is over valued or under valued. Whether Apollo Medical Holdings Inc is cheap or expensive depends on the assumptions which impact Apollo Medical Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMEH.

What is Apollo Medical Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Feb 21 2024, AMEH's PE ratio (Price to Earnings) is 50.6 and Price to Sales (PS) ratio is 1.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMEH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Apollo Medical Holdings Inc's stock?

In the past 10 years, Apollo Medical Holdings Inc has provided 0.503 (multiply by 100 for percentage) rate of return.